Gender Medicine (GM), also known as gender-specific medicine, addresses the biological and socio-cultural differences inherent to each individual and their impact on health and disease.

 

This innovative perspective holds great significance for National Health Services, marking a substantial cultural shift in patient care and presenting a new frontier in medical knowledge.

​

Initially, GM primarily focused on discerning clinical variations in diseases between men and women. However, today it encompasses a wide array of parameters for interpreting these differences. In recent years, global interest in studying sex differences - determined by biological characteristics - and gender differences - related to socioeconomic, cultural, and environmental factors - has surged.

​

This growing interest revolves around assessing the influence of such disparities on an individuals health and disease, aiming for precision medicine.

 

Now, the evaluation of sex and gender differences serves as a pivotal component for fostering equitable and tailored medicine. Incorporating these distinctions, which are closely tied to the identification and utilization of specific indicators highlighting male and female characteristics and disease outcomes, has become essential in achieving these objectives. Analyzing results in a disaggregated manner, categorized by specific groups and indicators, provides crucial insights to
inform optimal organizational decisions.

​

Recognizing and valuing gender differences enables us to deliver appropriate care, mitigate gender disparities in healthcare services, and ensure individuals receive the best possible care, resulting in significant cost savings for public healthcare systems.